Comprehensive Psychiatry
Volume 53, Issue 2 , Pages 130-139 , February 2012

Placing symptoms in context: the role of contextual criteria in reducing false positives in Diagnostic and Statistical Manual of Mental Disorders diagnoses

  • Jerome C. Wakefield

      Affiliations

    • Silver School of Social Work, New York, NY 10003, USA
    • Department of Psychiatry, School of Medicine, New York University, New York, NY 10016, USA
    • InSPIRES (Institute for Social and Psychiatric Initiatives–Research, Education and Services), Bellevue Hospital/New York University, New York, NY 10016, USA
    • Division of Clinical Phenomenology, Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 212 932 9705.
    • ,
  • Michael B. First

      Affiliations

    • Division of Clinical Phenomenology, Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    • New York State Psychiatric Institute, New York, NY 10032, USA

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed—Text Rev. Washington, DC: American Psychiatric Association; 2000;
  2. Wakefield JC. Disorder as harmful dysfunction: a conceptual critique of DSM-III-R's definition of mental disorder. Psychol Rev. 1992;99(2):232–247
  3. Wakefield JC. The concept of mental disorder: on the boundary between biological facts and social values. Am Psychol. 1992;47(3):373–388
  4. Wakefield JC. The concept of mental disorder: diagnostic implications of the harmful dysfunction analysis. World Psychiatry. 2006;6:149–156
  5. Wakefield JC, First MB. Clarifying the distinction between disorder and non-disorder: confronting the overdiagnosis (“false positives”) problem in DSM-V. In:  Phillips K,  First M,  Pincus H editor. Advancing DSM: dilemmas in psychiatric diagnosis. Washington, DC: American Psychiatric Press; 2003;p. 23–56
  6. Wakefield JC. Evolutionary versus prototype analyses of the concept of disorder. J Abnormal Psychology. 1999;108:374–399
  7. Klein DF. A proposed definition of mental illness. In:  Spitzer RL,  Klein DF editor. Critical issues in psychiatric diagnosis. New York: Raven Press; 1978;p. 41–71
  8. Boorse C. On the distinction between disease and illness. Philos Public Aff. 1975;5:49–68
  9. Boorse C. What a theory of mental health should be. J Soc Behav. 1976;6:61–84
  10. Bolton D. What is mental disorder?. Oxford, UK: Oxford University Press; 2008;
  11. Bolton D. Problems in the definition of “mental disorder”. Philos Q. 2001;51:182–199
  12. Cooper R. Disease. Stud Hist Phil Biol Biomed Sci. 2002;33:263–282
  13. Lilienfeld SO, Marino L. Essentialism revisited: evolutionary theory and the concept of mental disorder. J Abnormal Psychol. 1999;108(3):400–411
  14. Frances A. Problems in defining clinical significance in epidemiological studies. Arch Gen Psychiatry. 1998;55(2):119
  15. Spitzer RL, Wakefield JC. DSM-IV diagnostic criterion for clinical significance: does it help solve the false positives problem. Am J Psychiatry. 1999;156:1856–1864
  16. Wakefield JC. DSM-IV: are we making diagnostic progress?. Contemp Psychol. 1996;41:646–652
  17. Kendler KS. Review of the loss of sadness: how psychiatry transformed normal sorrow into depressive disorder by A.V. Horwitz and Jerome C. Wakefield. Psychol Med. 2008;38:148–150
  18. Jensen P, Hoagwood K. The book of names: DSM-IV in context. Dev Psychopathol. 1997;9:231–249
  19. Venuto V, Lautin A. The lure of the context-dependent psychiatric diagnosis. Psychiatric Times. 2009;26(6):http://www.psychiatrictimes.com/display/article/10168/1413515?verify=0 accessed 2/3/10. 2009
  20. Kendler KS, Myers J, Halberstad LJ. Should the diagnosis of major depression be made independent of or dependent upon the psychosocial context?. Psychol Med. 2010;40:771–780
  21. DSM-5 Anxiety Disorders Workgroup. 300.23 Social Phobia. http://www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid=163Accessed 4/21/10. 2010
  22. Horowitz AV, Wakefield JC. The loss of sadness: how psychiatry transformed normal sorrow into depressive disorder. New York: Oxford University Press; 2007;
  23. Kendler KS, Myers J, Zisook S. Does bereavement-related major depression differ from major depression associated with other stressful life events?. Am J Psychiatry. 2008;165(11):1449–1455
  24. Maj M. Depression, bereavement, and “understandable” intense sadness: should the DSM-IV approach be revised?. Am J Psychiatry. 2008;165(11):1373–1375
  25. Wakefield JC, Schmitz MF, First MB, Horwitz AV. Extending the bereavement exclusion for major depression to other losses: evidence from the National Comorbidity Survey. Arch Gen Psychiatry. 2007;64(4):433–440
  26. Kessler RC, Rubinow D, Holmes C, Aberson J, Zhao S. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med. 1997;27:1079–1089
  27. Wakefield JC, Pottick K, Kirk S. Should the DSM-IV diagnostic criteria for conduct disorder consider social context?. Am J Psychiatry. 2002;159:380–386
  28. Ruscio A, Lane M, Roy-Byrne P, Stang P, Stein D, Wittchen H, et al. Should excessive worry be required for a diagnosis of generalized anxiety disorder? Results from the US National Comorbidity Survey Replication. Psychol Med. 2005;35:1761–1772
  29. Slade T, Andrews G. DSM-IV and ICD-10 generalized anxiety disorder: discrepant diagnoses and associated disability. Soc Psychiatry Psychiatric Epidemiol. 2001;36(1):45–51
  30. Kessler R, Berglund P, Demler O, Jin R, Merikangas K, Walters E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602
  31. Wittchen H. Reliability and validity studies of the WHO Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res. 1994;28:57–84
  32. Kessler RC, Wittchen H, Abelson J, Kendler K, Knauper B, Shanyang Z. Methodological studies of the Composite International Diagnostic Interview (CIDI) in the US National Comorbidity Survey. Int J Methods Psychiatr Res. 1998;7:33–55

 Dr. Wakefield has no financial relationship with commercial interests or other conflicts of interest to report. Dr. First receives royalties from books related to DSM-IV (eg, DSM-IV Guidebook) and consults to pharmaceutical companies to provide diagnostic training for clinical trials. In the past 12 months, he has consulted with Cephalon, GlaxoSmithKline, Memory Pharmaceuticals, WorldwideClinical Trials, and i3 research.

PII: S0010-440X(11)00029-0

doi: 10.1016/j.comppsych.2011.03.001

Comprehensive Psychiatry
Volume 53, Issue 2 , Pages 130-139 , February 2012

Article Tools